Carisma Therapeutics Inc. Lease, Cost
Carisma Therapeutics Inc. reported Lease, Cost of $2.16 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2025-11-12
- Carisma Therapeutics Inc. lease, cost for the quarter ending 2025-09-30 was -$35.00K, a 101.74% decline year-over-year.
- Carisma Therapeutics Inc. lease, cost for the quarter ending 2025-06-30 was $865.00K, a 43.02% decline year-over-year.
- Carisma Therapeutics Inc. lease, cost for the quarter ending 2025-03-31 was $1.33M, a 61.84% decline year-over-year.
- Carisma Therapeutics Inc. lease, cost for the quarter ending 2024-12-31 was $1.78M, a 22.29% decline year-over-year.
- Carisma Therapeutics Inc. lease, cost for fiscal 2024 was $8.79M, a 0.51% decline from fiscal 2023.
- Carisma Therapeutics Inc. lease, cost for fiscal 2023 was $8.83M, a 39.28% increase from fiscal 2022.
- Carisma Therapeutics Inc. lease, cost for fiscal 2022 was $6.34M, a 976.74% increase from fiscal 2021.
- Carisma Therapeutics Inc. lease, cost for fiscal 2021 was $589.00K, a 4.80% increase from fiscal 2020.
| Period end | Lease, Cost 3 month | Lease, Cost 3 month as first filed | Lease, Cost 6 month | Lease, Cost 6 month as first filed | Lease, Cost 9 month | Lease, Cost 9 month as first filed | Lease, Cost 12 month | Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | -$35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $830.00K derived: sum of 2 quarters · filed 2025-11-12 | $2.16M 10-Q · filed 2025-11-12 | $3.93M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2025-06-30 | $865.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $2.19M 10-Q · filed 2025-08-07 | $3.97M derived: sum of 3 quarters · filed 2025-08-07 | $5.99M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2025-03-31 | $1.33M 10-Q · filed 2025-05-13 | $3.10M derived: sum of 2 quarters · filed 2025-05-13 | $5.12M derived: sum of 3 quarters · filed 2025-11-12 | $6.64M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $3.79M derived: sum of 2 quarters · filed 2025-11-12 | $5.31M derived: sum of 3 quarters · filed 2025-11-12 | $8.79M 10-K · filed 2025-03-31 | ||||
| 2024-09-30 | $2.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $3.54M derived: sum of 2 quarters · filed 2025-11-12 | $7.01M 10-Q · filed 2025-11-12 | $9.30M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $4.99M 10-Q · filed 2025-08-07 | $7.28M derived: sum of 3 quarters · filed 2025-08-07 | $9.62M derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | $3.48M 10-Q · filed 2025-05-13 | $5.76M derived: sum of 2 quarters · filed 2025-05-13 | $8.10M derived: sum of 3 quarters · filed 2025-05-13 | $9.78M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $4.62M derived: sum of 2 quarters · filed 2025-03-31 | $6.31M derived: sum of 3 quarters · filed 2025-03-31 | $8.83M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $2.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $4.02M derived: sum of 2 quarters · filed 2024-11-07 | $6.54M 10-Q · filed 2024-11-07 | $5.33M 10-Q · filed 2023-11-09 | $9.24M derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | $1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $4.21M 10-Q · filed 2024-08-08 | $3.56M 10-Q · filed 2023-08-10 | $6.91M derived: sum of 3 quarters · filed 2024-08-08 | $8.63M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | $2.52M 10-Q · filed 2024-05-09 | $1.77M 10-Q · filed 2023-05-11 | $5.22M derived: sum of 2 quarters · filed 2024-05-09 | $6.95M derived: sum of 3 quarters · filed 2024-05-09 | $8.40M derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $4.42M derived: sum of 2 quarters · filed 2024-04-01 | $5.88M derived: sum of 3 quarters · filed 2024-04-01 | $6.34M 10-K · filed 2024-04-01 | $458.00K 10-K · filed 2023-02-28 | |||
| 2022-09-30 | $1.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $3.18M derived: sum of 2 quarters · filed 2023-11-09 | $3.65M 10-Q · filed 2023-11-09 | |||||
| 2022-06-30 | $1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.92M 10-Q · filed 2023-08-10 | ||||||
| 2022-03-31 | $465.00K 10-Q · filed 2023-05-11 | |||||||
| 2021-12-31 | $589.00K 10-K · filed 2023-02-28 | |||||||
| 2020-12-31 | $562.00K 10-K · filed 2022-02-28 | |||||||
| 2019-12-31 | $151.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $286.00K derived: sum of 2 quarters · filed 2021-03-15 | $410.00K derived: sum of 3 quarters · filed 2021-03-15 | $561.00K 10-K · filed 2021-03-15 | ||||
| 2019-09-30 | $135.00K 10-Q · filed 2019-11-12 | $259.00K derived: sum of 2 quarters · filed 2019-11-12 | $410.00K 10-Q · filed 2019-11-12 | |||||
| 2019-06-30 | $124.00K 10-Q · filed 2019-08-08 | $275.00K 10-Q · filed 2019-08-08 | ||||||
| 2019-03-31 | $151.00K 10-Q · filed 2019-05-10 |